STARHEALTH
Star Health and Allied Insurance Company Limited
Star Health and Allied Insurance Company Limited (STARHEALTH) financial statements and selected valuation metrics through 31 March 2026.
Financial Services›Financial Services›Insurance›General Insurance
starhealth.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Star Health sells health insurance to individuals and families across India, mostly through its own distribution channels, and describes its aim as keeping leadership in retail health insurance (January 2026 press release).
Company snapshot
3rdBy market cap
Ranked among 6 companies in General Insurance.
What we see
- ✓Cash flow from operations is higher than reported profit — earnings quality looks solid.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Insurance layout · ₹ Cr · quarterly
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium | 2,943 Cr | 3,993 Cr | 2,801 Cr | 3,545 Cr | 3,152 Cr | 3,170 Cr | 3,560 Cr | 4,820 Cr | 3,457 Cr | 4,233 Cr | 4,361 Cr | 5,599 Cr |
| Expenses | 511 Cr | 611 Cr | 541 Cr | 596 Cr | 600 Cr | 572 Cr | 631 Cr | 684 Cr | 620 Cr | 676 Cr | 780 Cr | 884 Cr |
| Operating profit | 2,432 Cr | 3,382 Cr | 2,260 Cr | 2,948 Cr | 2,552 Cr | 2,598 Cr | 2,930 Cr | 4,136 Cr | 2,838 Cr | 3,557 Cr | 3,581 Cr | 4,715 Cr |
| Investment income | — | — | — | — | — | — | — | — | — | — | — | — |
| Other income | 116 Cr | 141 Cr | 146 Cr | 151 Cr | 163 Cr | 0.42 Cr | 2 Cr | 2 Cr | 0.36 Cr | 3 Cr | 2 Cr | 2 Cr |
| Profit before tax | 282 Cr | 136 Cr | 384 Cr | 167 Cr | 388 Cr | 426 Cr | 287 Cr | -0.87 Cr | 352 Cr | 78 Cr | 173 Cr | 151 Cr |
| Tax % | 25.3% | 25.2% | 25.1% | 25.0% | 25.3% | 25.2% | 25.0% | 158.6% | 25.4% | 29.3% | 26.1% | 26.4% |
| Net profit | 210 Cr | 102 Cr | 288 Cr | 125 Cr | 290 Cr | 319 Cr | 215 Cr | 0.51 Cr | 263 Cr | 55 Cr | 128 Cr | 111 Cr |
| EPS (₹) | ₹3.63 | ₹1.75 | ₹4.95 | ₹2.15 | ₹4.95 | ₹5.45 | ₹3.66 | ₹0.01 | ₹4.47 | ₹0.93 | ₹2.18 | ₹1.89 |
Profit & loss (annual)
Annual insurance P&L · TTM where available · ₹ Cr
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Premium | 3,580 Cr | 4,693 Cr | 5,023 Cr | 10,809 Cr | 12,320 Cr | 12,938 Cr | 15,525 Cr | 17,650 Cr | Sign in free for the trailing twelve months |
| Expenses | — | — | — | 1,839 Cr | 2,054 Cr | — | 2,541 Cr | 2,960 Cr | Sign in free for the trailing twelve months |
| Operating profit | — | — | — | 8,971 Cr | 10,266 Cr | — | 12,985 Cr | 14,690 Cr | Sign in free for the trailing twelve months |
| Investment income | — | — | — | — | — | — | — | — | Sign in free for the trailing twelve months |
| Other income | — | — | — | 480 Cr | 501 Cr | — | 6 Cr | 7 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 182 Cr | 413 Cr | -1,046 Cr | -1,397 Cr | 826 Cr | 1,129 Cr | 861 Cr | 754 Cr | Sign in free for the trailing twelve months |
| Tax % | 29.6% | 35.2% | 21.1% | 25.5% | 25.1% | 25.1% | 25.0% | 26.2% | Sign in free for the trailing twelve months |
| Net profit | 128 Cr | 268 Cr | -826 Cr | -1,041 Cr | 619 Cr | 845 Cr | 646 Cr | 557 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹2.81 | ₹5.59 | ₹-16.54 | ₹-18.65 | ₹10.70 | ₹14.48 | ₹11.01 | ₹9.47 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.0% | — | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 456 Cr | 491 Cr | 548 Cr | 576 Cr | 582 Cr | 585 Cr | 588 Cr | 588 Cr |
| Reserves | 937 Cr | 1,154 Cr | 3,673 Cr | 5,794 Cr | 5,984 Cr | 5,799 Cr | 6,436 Cr | 7,001 Cr |
| Borrowings | 250 Cr | 250 Cr | 250 Cr | 720 Cr | 470 Cr | 470 Cr | 470 Cr | 470 Cr |
| Other liabilities | — | 2 Cr | — | 8,190 Cr | 8,191 Cr | 348 Cr | 13,291 Cr | 16,005 Cr |
| Total liabilities | 1,643 Cr | 1,897 Cr | 4,467 Cr | 15,279 Cr | 15,226 Cr | 7,202 Cr | 20,785 Cr | 24,064 Cr |
| Fixed assets (net) | — | — | — | 117 Cr | 111 Cr | — | 185 Cr | 180 Cr |
| CWIP | — | — | — | — | — | — | — | — |
| Investments | — | — | — | 11,373 Cr | 13,392 Cr | — | 17,898 Cr | 20,012 Cr |
| Cash & bank | 893 Cr | 611 Cr | 1,879 Cr | 564 Cr | 309 Cr | 445 Cr | 668 Cr | 1,444 Cr |
| Other assets | 750 Cr | 1,285 Cr | 2,588 Cr | 3,225 Cr | 1,413 Cr | 6,757 Cr | 2,033 Cr | 2,428 Cr |
| Total assets | 1,643 Cr | 1,897 Cr | 4,467 Cr | 15,279 Cr | 15,226 Cr | 7,202 Cr | 20,785 Cr | 24,064 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 776 Cr | 647 Cr | 890 Cr | 56 Cr | 1,276 Cr | 1,310 Cr | 1,379 Cr | 1,873 Cr |
| Cash from investing | -731 Cr | -1,006 Cr | -2,418 Cr | -3,786 Cr | -1,097 Cr | -1,177 Cr | -1,151 Cr | -1,067 Cr |
| Cash from financing | 333 Cr | 122 Cr | 2,613 Cr | 2,509 Cr | -268 Cr | 23 Cr | -4 Cr | -31 Cr |
| Net cash flow | 379 Cr | -237 Cr | 1,086 Cr | -1,221 Cr | -89 Cr | 156 Cr | 224 Cr | 775 Cr |
| Free cash flow (OCF − Capex) | 738 Cr | 614 Cr | 844 Cr | -8 Cr | 1,229 Cr | 1,186 Cr | 1,296 Cr | 1,795 Cr |
Ratios
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | — | — | — | — | — | — | — |
| ROE % | 9.2% | 16.3% | -19.6% | -16.3% | 9.4% | 13.2% | 9.2% | 7.3% |
| Debtor days | — | — | — | — | — | — | — | — |
| Inventory days | — | — | — | — | — | — | — | — |
| Days payable | — | — | — | — | — | — | — | — |
| Cash conversion cycle | — | — | — | — | — | — | — | — |
| Debt / equity | 0.18 | 0.15 | 0.06 | 0.11 | 0.07 | 0.07 | 0.07 | 0.06 |
| Current ratio | — | — | — | 0.64 | 0.57 | — | 0.57 | 0.60 |
| Net debt / EBITDA | — | — | — | — | — | — | — | — |
Regulatory ratios (as filed, standalone basis)
IRDAI ratios as filed with results. Key metrics may show the investor-deck figure, which can differ.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Solvency ratio | 167.0% | 214.0% | — | 221.0% | 205.0% |
| Claims ratio | 87.1% | 65.0% | — | 70.3% | 68.5% |
| Combined ratio | 117.9% | 95.3% | — | 101.1% | 100.4% |
| Expenses of management ratio | 30.1% | 30.0% | — | 31.1% | 32.3% |
| Net retention ratio | 94.3% | 95.1% | — | 92.5% | 94.9% |